Beam Therapeutics Inc

Beam Therapeutics Inc

BEAM · NASDAQ
BEAM · NASDAQ
26.42
USD0.421.63%

Latest News

    AMB Crypto

    984M BEAM stolen, then burned – The move that turned a hack into a pump

      CoinOtag

      BEAM Tops Upbit's Won-Market Volume at 113.1 Billion Won on Saturday

        CoinOtag

        Coinbase to List BEAM (BEAM) as BEAM-USD Trading Begins December 16, 2025

          NullTx

          Whale Shifts Focus: $PEPE and $BEAM Sold at a Loss to Enter $ONDO – What’s Driving the Move?

            NullTx

            4 Low-Cap Altcoins Outside The Top 100 Cryptos That Could Be Set To Follow Sui (SUI) Into The Top 15 (SUI, W (wormhole), BRETT, BEAM, RTX)

              crypto.news

              Coinbase to add perpetual futures for AERO, BEAM and DRIFT

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              26.17USD
              27.31USD

              52 Week Range

              20.23USD
              38.26USD

              Market Cap

              2.81BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US07373V1052

              CUSIP

              07373V105

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -

              Book Value

              10.69

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -0.68

              Wall Street Target Price

              49.38

              EPS Estimate Current Year

              -4.46

              EPS Estimate Next Year

              -4.75

              EPS Estimate Current Quarter

              -1.126

              EPS Estimate Next Quarter

              -1.1744

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              156,035,008

              Gross Profit TTM

              -252,628,992

              EBITDA

              -355,780,992

              Profit Margin

              -55.45%

              Return On Assets TTM

              -17.01%

              Return On Equity TTM

              -8.18%

              Revenue Per Share TTM

              1.511

              Qtly Revenue Growth YOY

              -94.20%

              Diluted Eps TTM

              -0.68

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              18.0249

              Price Book MRQ

              2.6368

              Enterprise Value Revenue

              12

              Enterprise Value EBITDA

              -7

              Peers analysis

              • argenx NV ADR
                ARGXargenx NV ADR

                903.08

                3.20%
              • Moderna Inc
                MRNAModerna Inc

                227.40

                2.97%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                965.00

                0.55%
              • UCB SA
                UCBJFUCB SA

                314.92

                0.35%
              • argenx SE
                ARGNFargenx SE

                900.30

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                139.16

                0.00%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                528.21

                -4.77%
              • Be
                ONCBeiGene, Ltd.

                355.10

                -2.26%
              • CSL Ltd
                CSLLYCSL Ltd

                34.64

                -2.01%
              • UCB SA ADR
                UCBJYUCB SA ADR

                153.70

                -1.47%

              FAQs

              What is Beam Therapeutics Inc stock price today?

              What is Beam Therapeutics Inc stock ticker?

              Is BEAM stock price going up?

              What is the analyst recommendation for BEAM?

              What is BEAM market cap?

              Does BEAM release financial reports?

              When is BEAM next earnings date?

              What were BEAM Earnings for the last quarter?

              What was BEAM Revenue for the last quarter?

              What was BEAM Net Income for the last quarter?

              Does BEAM pay dividends?

              How many employees does BEAM have?

              What is BEAM EBITDA?

              How to buy BEAM stocks?

              Should I invest in BEAM stock?